Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Padget · SciRah

Researcher profile · Semantic Scholar

M. Padget

Share profile

M. Padget — researcher profile on SciRah

h-index: 16
Works: 40
Citations: 1,323

Most-cited papers

Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study
Erika J. Lampert, A. Zimmer, M. Padget, A. Cimino-Mathews +14 more
2020Clinical Cancer Research180 citations Open access
Semantic Scholar
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
C. Jochems, J. Hodge, M. Fantini, Rika Fujii +11 more
2016OncoTarget177 citations Open access
Semantic Scholar
Cisplatin and Oxaliplatin Induce Similar Immunogenic Changes in Preclinical Models of Head and Neck Cancer
So-Jin Park, Wenda Ye, Roy Xiao, Christopher Silvin +4 more
2019Oral Oncology156 citations Open access
Semantic Scholar
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Kimberly L. Cramer-Morales, M. Nieborowska-Skorska, Kara A. Scheibner, M. Padget +14 more
2013Blood148 citations Open access
Semantic Scholar
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
Kellsye P. Fabian, M. Padget, R. Donahue, K. Solocinski +7 more
2020Journal for ImmunoTherapy of Cancer142 citations Open access
Semantic Scholar
Overcoming hypoxia-induced functional suppression of NK cells
K. Solocinski, M. Padget, Kellsye P. Fabian, Benjamin Wolfson +7 more
2020Journal for ImmunoTherapy of Cancer67 citations Open access
Semantic Scholar
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
Kathleen E. Fenerty, M. Padget, Benjamin Wolfson, S. Gameiro +5 more
2018Journal of Immunotherapy for Cancer64 citations Open access
Semantic Scholar
Efficient ADCC- killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Amber J. Giles, Shu-Yu Hao, M. Padget, Hua Song +17 more
2019JCI Insight55 citations Open access
Semantic Scholar
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve
Kellsye P. Fabian, M. Padget, Rika Fujii, J. Schlom +1 more
2021Journal for ImmunoTherapy of Cancer51 citations Open access
Semantic Scholar
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
Y. Robbins, Sarah Greene, J. Friedman, Paul E. Clavijo +10 more
2020bioRxiv47 citations Open access
Semantic Scholar
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
J. Friedman, M. Morisada, Lillian D. Sun, E. Moore +5 more
2018Journal of Immunotherapy for Cancer45 citations Open access
Semantic Scholar
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
Maxwell Y. Lee, Y. Robbins, C. Sievers, J. Friedman +11 more
2021Journal for ImmunoTherapy of Cancer38 citations Open access
Semantic Scholar
Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia
Takayo Sasaki, J. Rivera-Mulia, Daniel L. Vera, Jared Zimmerman +10 more
2017Experimental Hematology29 citations Open access
Semantic Scholar
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells
J. Friedman, M. Padget, John H. Lee, J. Schlom +2 more
2019Oral Oncology25 citations Open access
Semantic Scholar
Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
Benjamin Wolfson, M. Padget, J. Schlom, J. Hodge
2021Journal for ImmunoTherapy of Cancer23 citations Open access
Semantic Scholar
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Austin T. K. Hoke, M. Padget, Kellsye P. Fabian, Anjali Nandal +5 more
2021Cancer Research Communications16 citations Open access
Semantic Scholar
Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models
Kellsye P. Fabian, Ginette S. Santiago-Sánchez, M. Padget, W. Lassoued +4 more
2024Journal for ImmunoTherapy of Cancer13 citations
Semantic Scholar
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable
Kellsye P. Fabian, Anthony S. Malamas, M. Padget, K. Solocinski +5 more
2020Cancer immunology research13 citations Open access
Semantic Scholar
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
S. E. Franks, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, K. Solocinski +7 more
2023Cancer Immunology and Immunotherapy9 citations Open access
Semantic Scholar
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach
Austin T. K. Hoke, Y. Takahashi, M. Padget, Javier A. Gomez +8 more
2024Translational Oncology8 citations Open access
Semantic Scholar
In-hospital cardiac arrests: effect of amended Australian Resuscitation Council 2006 guidelines.
M. Boyde, M. Padget, Elizabeth A. Burmeister, L. Aitken
2013Australian Health Review8 citations Open access
Semantic Scholar
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies
Josh Kowalczyk, Kellsye P. Fabian, M. Padget, D. Lopez +5 more
2022Journal for ImmunoTherapy of Cancer7 citations Open access
Semantic Scholar
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence
D. Lopez, Kellsye P. Fabian, M. Padget, Y. Robbins +8 more
2024Frontiers in Oncology6 citations Open access
Semantic Scholar
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models
F. Rosato, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, M. Padget +8 more
2025Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regression
Ginette S. Santiago-Sánchez, F. Rosato, Kellsye P. Fabian, M. Padget +12 more
2026Journal for ImmunoTherapy of Cancer0 citations Open access
Semantic Scholar
Abstract B020: Examination of a novel bi-functional TCR activating molecule in combination with docetaxel in breast and prostate cancer models
Jonelle K Lee, Kellsye P. Fabian, Ginette S. Santiago-Sánchez, F. Rosato +10 more
2026Cancer immunology research0 citations
Semantic Scholar
Docetaxel enhances Vβ-directed T-cell activation and antitumor immunity mediated by a bifunctional TCR agonist in breast and prostate cancer models
Jonelle K Lee, Kellsye P. Fabian, Ginette S. Santiago-Sánchez, F. Rosato +9 more
2026Frontiers in Immunology0 citations Open access
Semantic Scholar
Abstract A028: Combination therapy with a TCR Vβ-directed bifunctional molecule, cisplatin and anti-PD-1 promotes antitumor activity in immune checkpoint blockade-refractory head and neck murine tumor models
F. Rosato, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, M. Padget +8 more
2026Cancer immunology research0 citations
Semantic Scholar
629 Triple combination therapy with a TCR Vb-directed bifunctional molecule, cisplatin and anti-PD-1 in immune checkpoint blockade-refractory head and neck murine tumor models
F. Rosato, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, M. Padget +9 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
625 Docetaxel enhances the anti-tumor activity of a novel bi-functional TCR activating molecule in breast and prostate cancer models
Jonelle K Lee, Kellsye P. Fabian, Ginette S. Santiago-Sánchez, F. Rosato +10 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
12P A novel anti-TCR Vb targeted bispecific antibody in combination with a poly ADP ribose polymerase inhibitor (PARPi) enhances anti-tumor immune response in a prostate cancer model
G. S. Santiago-Sanchez, F. Rosato, M. Padget, J. Schlom +6 more
2025ESMO Open0 citations Open access
Semantic Scholar
916 A novel anti-TCR Vb targeted bispecific antibody in combination with a poly ADP-ribose polymerase inhibitor (PARPi) enhances anti-tumor immune response in prostate cancer models
Ginette S. Santiago-Sánchez, F. Rosato, Kellsye P. Fabian, M. Padget +10 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
NK Cell-Based Immunotherapy Approaches to Sinonasal Undifferentiated Carcinoma
Austin T K Hoke, Yoko Takahashi, M. Padget, M. Amit +8 more
202332nd Annual Meeting North American Skull Base Society0 citations
Semantic Scholar
Author response: Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
Y. Robbins, Sarah Greene, J. Friedman, Paul E. Clavijo +10 more
20200 citations Open access
Semantic Scholar
Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
Kathleen E. Fenerty, M. Padget, Benjamin Wolfson, S. Gameiro +5 more
2019Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar
EXTH-63. EFFICIENT ADCC-MEDIATED KILLING OF MALIGNANT MENINGIOMA CELLS USING AVELUMAB AND AN ENGINEERED HIGH AVIDITY NATURAL KILLER CELL LINE, haNK
Amber J. Giles, Shu-Yu Hao, R. Fuji, M. Padget +14 more
2018Neuro-Oncology0 citations Open access
Semantic Scholar
Immunotherapy utilizing the combined use of NK and ADCC mediating agents with PARP inhibition.
Kathleen E. Fenerty, M. Padget, J. Schlom, J. Hodge
20180 citations
Semantic Scholar
Exploiting Immunogenic Modulation in Chordoma: Sublethal Radiation Increases EGFR Expression and Sensitizes Tumor Cells to Cetuximab
J. Griner, M. Padget, J. Hodge
2017The FASEB Journal0 citations Open access
Semantic Scholar
Abstract 3385: Expression of CD22, a late B lymphoid antigen, does not distinguish leukemia stem cells from the bulk population in acute lymphoblastic leukemia cases
Diana Heckel, M. Padget, Srujana Cherukuri, Sebastien Morisot +4 more
20120 citations
Semantic Scholar
PD-L1targetinghigh-affinityNK (t-haNK)cellsinducedirectantitumor effectsandtargetsuppressive MDSCpopulations
Kellsye P. Fabian, M. Padget, R. Donahue, K. Solocinski +7 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Hodge×23
Invite
J. Hodge — researcher profile on SciRah
Kellsye P. Fabian×20
Invite
Kellsye P. Fabian — researcher profile on SciRah
J. Schlom×14
Invite
J. Schlom — researcher profile on SciRah
P. Soon-Shiong×11
Invite
P. Soon-Shiong — researcher profile on SciRah

Ginette S. Santiago-Sánchez

×10

Invite

Ginette S. Santiago-Sánchez — researcher profile on SciRah

Invite

J. Schlom — researcher profile on SciRah

Invite

F. Rosato — researcher profile on SciRah

M. Katragadda×9

Invite

M. Katragadda — researcher profile on SciRah

Invite

J. Moisan — researcher profile on SciRah

Invite

A. Bayliffe — researcher profile on SciRah

Invite

John H. Lee — researcher profile on SciRah

James W. Hodge×8

Invite

James W. Hodge — researcher profile on SciRah